Sinnberg, Tobias <br/><br/>
A Nexus Consisting of Beta-Catenin and Stat3 Attenuates BRAF Inhibitor Efficacy and Mediates Acquired Resistance to Vemurafenib.  [electronic resource] 

 -  EBioMedicine  Jun 2016 
 - 132-149 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>2352-3964 
<br/><br/><label>Standard No.: </label>10.1016/j.ebiom.2016.04.037  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--pharmacology<br/>Apoptosis--drug effects<br/>Cell Cycle--drug effects<br/>Cell Line, Tumor<br/>Cell Survival--drug effects<br/>Disease Models, Animal<br/>Drug Resistance, Neoplasm--genetics<br/>Gene Knockdown Techniques<br/>Humans<br/>Indoles--pharmacology<br/>Melanoma--drug therapy<br/>Mice<br/>Protein Kinase Inhibitors--pharmacology<br/>Proto-Oncogene Proteins B-raf--antagonists & inhibitors<br/>Resin Cements<br/>STAT3 Transcription Factor--metabolism<br/>Sulfonamides--pharmacology<br/>Vemurafenib<br/>Wnt Signaling Pathway--drug effects<br/>Xenograft Model Antitumor Assays<br/>beta Catenin--genetics